美国 · SEC FORM 4
Cingulate Inc.
CING · Nasdaq · CIK 0001862150 · Healthcare · Biotechnology
内部人信号
0 qualifying P purchase groups
当前 180 天评分窗口
0 同一窗口内观察到的 Form 4 交易行
0 sales · 0 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号？
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
内部人活动时间轴
当前 180 天窗口内没有 Form 4 交易事件。
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后，这些模块才会启用。
信号历史
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2026-02-06 · Werth Peter J..
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 1,031,388
- 上期报告
- 1,170,285
- 日均成交量
- 98,278
- 回补天数
- 10.5
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-02-06 | Werth Peter J. | 买入 (P) | Common Stock | 19,455 | USD 5.04 | USD 98,053 | SEC 申报 ↗ |
| 2026-02-06 | Schaffer Shane J. | 买入 (P) | Common Stock | 6,809 | USD 5.04 | USD 34,317 | SEC 申报 ↗ |
| 2026-02-06 | Callahan Jennifer L. | 买入 (P) | Common Stock | 4,864 | USD 5.04 | USD 24,515 | SEC 申报 ↗ |
| 2026-02-06 | Brams Matthew | 买入 (P) | Common Stock | 1,946 | USD 5.04 | USD 9,808 | SEC 申报 ↗ |
| 2023-09-15 | Callahan Jennifer L. | 买入 (P) | Common Stock | 5,000 | USD 0.67 | USD 3,350 | SEC 申报 ↗ |
| 2023-08-11 | Werth Peter J. | 买入 (P) | Common Stock | 1,823,155 | USD 0.55 | USD 1,002,735 | SEC 申报 ↗ |
| 2023-05-15 | Callahan Jennifer L. | 买入 (P) | Common Stock | 2,000 | USD 1.01 | USD 2,020 | SEC 申报 ↗ |
| 2023-05-12 | Callahan Jennifer L. | 买入 (P) | Common Stock | 4,000 | USD 1.08 | USD 4,320 | SEC 申报 ↗ |
| 2022-12-16 | Schaffer Shane J. | 买入 (P) | Common Stock | 10,000 | USD 1.02 | USD 10,200 | SEC 申报 ↗ |
| 2022-12-14 | Schaffer Shane J. | 买入 (P) | Common Stock | 13,267 | USD 1.01 | USD 13,400 | SEC 申报 ↗ |
| 2022-12-14 | Callahan Jennifer L. | 买入 (P) | Common Stock | 7,548 | USD 0.99 | USD 7,473 | SEC 申报 ↗ |
| 2022-12-13 | Werth Peter J. | 买入 (P) | Common Stock | 28,934 | USD 0.98 | USD 28,355 | SEC 申报 ↗ |
| 2022-12-13 | Schaffer Shane J. | 买入 (P) | Common Stock | 1,733 | USD 1.01 | USD 1,750 | SEC 申报 ↗ |
| 2022-11-29 | Callahan Jennifer L. | 买入 (P) | Common Stock | 1,530 | USD 0.98 | USD 1,499 | SEC 申报 ↗ |
| 2022-11-28 | Callahan Jennifer L. | 买入 (P) | Common Stock | 3,487 | USD 0.98 | USD 3,417 | SEC 申报 ↗ |
Form 4 申报证据
14 transaction lines in the latest 365-day window; 56 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-03-09 | Silva Raul R. | 代扣税 (F) | Common Stock | 1,828 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-09 | Silva Raul R. | 奖励／授予 (A) | Common Stock | 4,526 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-09 | Schaffer Shane J. | 代扣税 (F) | Common Stock | 2,959 | USD 0.00 | USD 0 | SEC 申报 ↗ |
展开近期 Form 4 证据 (14 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-03-09 | Silva Raul R. | 代扣税 (F) | Common Stock | 1,828 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-09 | Silva Raul R. | 奖励／授予 (A) | Common Stock | 4,526 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-09 | Schaffer Shane J. | 代扣税 (F) | Common Stock | 2,959 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-09 | Schaffer Shane J. | 奖励／授予 (A) | Common Stock | 6,862 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-09 | Patel Nilay Dahyabhai | 代扣税 (F) | Common Stock | 2,086 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-09 | Patel Nilay Dahyabhai | 奖励／授予 (A) | Common Stock | 5,475 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-09 | Callahan Jennifer L. | 代扣税 (F) | Common Stock | 6,427 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-09 | Callahan Jennifer L. | 奖励／授予 (A) | Common Stock | 15,329 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-09 | Brams Matthew | 代扣税 (F) | Common Stock | 1,025 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-09 | Brams Matthew | 奖励／授予 (A) | Common Stock | 4,526 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-06 | Werth Peter J. | 买入 (P) | Common Stock | 19,455 | USD 5.04 | USD 98,053 | SEC 申报 ↗ |
| 2026-02-06 | Schaffer Shane J. | 买入 (P) | Common Stock | 6,809 | USD 5.04 | USD 34,317 | SEC 申报 ↗ |
| 2026-02-06 | Callahan Jennifer L. | 买入 (P) | Common Stock | 4,864 | USD 5.04 | USD 24,515 | SEC 申报 ↗ |
| 2026-02-06 | Brams Matthew | 买入 (P) | Common Stock | 1,946 | USD 5.04 | USD 9,808 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | CING |
| CIK | 0001862150 |
| 行业 | Healthcare |
| 细分行业 | Biotechnology Yahoo Finance |
| SEC SIC | 2834 Pharmaceutical Preparations |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 56 transaction lines from 2021-12-10 to 2026-03-09 41 P purchase lines · 2 S sale lines · 13 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.